SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-073324
Filing Date
2024-03-21
Accepted
2024-03-21 08:00:31
Documents
15
Period of Report
2024-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d795577d8k.htm   iXBRL 8-K 25792
2 EX-99.1 d795577dex991.htm EX-99.1 58924
6 GRAPHIC g795577dsp001.jpg GRAPHIC 7239
  Complete submission text file 0001193125-24-073324.txt   230758

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iron-20240321.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20240321_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20240321_pre.xml EX-101.PRE 11718
18 EXTRACTED XBRL INSTANCE DOCUMENT d795577d8k_htm.xml XML 3765
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 24769522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)